Out of stock

This item is currently unavailable

Sold out. We send one email the moment it's back.

Out of stock 3 days

World Outlook for Breast Cancer Screenings 2025-2030

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

View at Amazon ↗
Out of stock

Price data checked 3 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

No price data available for histogram

Description

This comprehensive study provides a detailed world outlook for breast cancer screenings from 2025 to 2030. Covering more than 190 countries, the report offers essential data for understanding global market dynamics and healthcare trends. Each year of the projection includes estimates for latent demand, also known as potential industry earnings (P.I.E.), expressed in millions of U.S. dollars. The report provides regional and global percent share data for each country, allowing for quick comparative benchmarking. By using econometric models to project fundamental economic dynamics, this study helps readers gauge specific country performance against others on a global scale.

Key Features

Covers a global outlook for breast cancer screenings across more than 190 countries.

Provides annual estimates for latent demand and potential industry earnings (P.I.E.) in millions of U.S. dollars.

Includes percent share data for each country relative to its region and the entire globe.

Utilizes econometric models to project fundamental economic dynamics within and across countries.

Offers comparative benchmarks to help readers gauge country performance against others.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
05 April 2024

Similar Products You Might Like

World Outlook for Breast Cancer Diagnostic Products 2025-2030
99% match

World Outlook for Breast Cancer Diagnostic Products 2025-2030

Price unavailable
2023-2028 US Breast Cancer Screening Outlook Study
99% match

2023-2028 US Breast Cancer Screening Outlook Study

£520.00 07 Nov 2026
The 2023-2028 Outlook for Breast Cancer Screenings in China
99% match

The 2023-2028 Outlook for Breast Cancer Screenings in China

£495.00 02 Nov 2026
The 2023-2028 Outlook for Breast Cancer Screenings in Japan
98% match

The 2023-2028 Outlook for Breast Cancer Screenings in Japan

£495.00 04 Nov 2026
The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing
98% match

The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing

£795.00 26 Sep 2026
The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy
98% match

The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy

Price unavailable
2023-2028 US Breast Cancer Screening Outlook by Zip Code
98% match

2023-2028 US Breast Cancer Screening Outlook by Zip Code

£490.00 05 Nov 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in China
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in China

£495.00 26 Sep 2026
US Breast Cancer Diagnostic Products Outlook 2023-2028
98% match

US Breast Cancer Diagnostic Products Outlook 2023-2028

£520.00 06 Nov 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in India

£515.00 02 Oct 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in the United States

£520.00 01 Oct 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in Japan
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing in Japan

£495.00 02 Oct 2026
India Breast Cancer Diagnostic Products Outlook 2023-2028
98% match

India Breast Cancer Diagnostic Products Outlook 2023-2028

£515.00 05 Nov 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in Japan
98% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in Japan

£495.00 03 Nov 2026
World Outlook for Triple-Negative Breast Cancer Treatments
98% match

World Outlook for Triple-Negative Breast Cancer Treatments

Price unavailable
The 2021-2026 World Outlook for Breast Biopsies
98% match

The 2021-2026 World Outlook for Breast Biopsies

Price unavailable
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes
98% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes

£490.00 03 Oct 2026
HER-2 Positive Breast Cancer Chemotherapy Outlook India
98% match

HER-2 Positive Breast Cancer Chemotherapy Outlook India

£515.00 07 Nov 2026
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in China
98% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in China

£495.00 31 Oct 2026
Breast Cancer Diagnostic Products Outlook 2023-2028 Report
98% match

Breast Cancer Diagnostic Products Outlook 2023-2028 Report

£490.00 05 Nov 2026
The 2026-2031 World Outlook for Breast Cancer Liquid Biopsies
98% match

The 2026-2031 World Outlook for Breast Cancer Liquid Biopsies

£885.00 20 Oct 2026
The 2025-2030 World Outlook for Digital Breast Tomosynthesis
98% match

The 2025-2030 World Outlook for Digital Breast Tomosynthesis

Price unavailable
HER-2 Positive Breast Cancer Chemotherapy Outlook 2023-2028
98% match

HER-2 Positive Breast Cancer Chemotherapy Outlook 2023-2028

£520.00 04 Nov 2026
The 2023 Report on Women's Diagnostic Breast Cancer Testing: World Market Segmentation by City
98% match

The 2023 Report on Women's Diagnostic Breast Cancer Testing: World Market Segmentation by City

£795.00 02 Oct 2026